德克萨米他增强了急性骨髓性白血病细胞中的venetoclax诱导的亡
Haixia Wang1, Junjie Zhou1, Xiaoyu Ma1
1Department of Hematology, The First Affiliated Hospital of Anhui Medical University, Hefei, 230022, China.
Medical oncology (Northwood, London, England)
|June 1, 2023
概括
将venetoclax与德克萨米他结合使用可以增强急性髓性白血病 (AML) 的治疗效果. 这种组合通过减少保护性线粒体从骨髓中介质 stromal 细胞 (BM-MSCs) 到白血病细胞的转移来克服抗性.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 细胞生物学 细胞生物学
背景情况:
- 向BCL-2改善了急性髓性白血病 (AML) 治疗方法,但抵抗机制仍然存在.
- 骨髓中酶体 stromal 细胞 (BM-MSCs) 通过线粒体转移保护AML细胞免受亡,从而促进治疗耐药性.
- 作为BCL-2抑制剂的Venetoclax是一种关键的AML疗法,但耐药性限制了它的有效性.
研究的目的:
- 研究德克萨米他在AML中增强venetoclax抗瘤作用的潜力.
- 阐明甲松调节venetoclax疗效的机制,特别是在BM-MSC相互作用的背景下.
主要方法:
- 在AML细胞与BM-MSCs的共同培养中.
- 治疗AML细胞单独使用venetoclax和结合使用德甲.
- 评估细胞亡,活性氧物种 (ROS) 水平和线粒体转移.
主要成果:
- 德克萨米他单独没有影响AML细胞活力,但显著增强了venetoclax诱导的亡.
- 在与BM-MSCs共同培养中,组合治疗显示出比单独使用venetoclax更大的抗瘤效果.
- 德甲降低了venetoclax诱导的ROS和线粒体从BM-MSCs转移到AML细胞,从而降低了BM-MSCs的保护作用.
结论:
- 威尼托克拉克斯与德甲结合显示为AML的有前途的治疗策略.
- 这种组合通过减少线粒体转移和增强亡来克服BM-MSC介导的耐药性.
- 针对AML细胞和BM-MSC之间的相互作用提供了一种新的方法来改善AML治疗结果.
相关概念视频
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
359
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
359
Combination Therapies and Personalized Medicine
5.0K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.0K
The Intrinsic Apoptotic Pathway
6.6K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.6K
Drugs that Destabilize Microtubules
2.0K
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
2.0K
Apoptosis
11.6K
Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size...
11.6K
The Extrinsic Apoptotic Pathway
6.5K
The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
6.5K


